Literature DB >> 16963052

Non-transferrin-bound iron is associated with plasma level of soluble intercellular adhesion molecule-1 but not with in vivo low-density lipoprotein oxidation.

L J H van Tits1, E M G Jacobs, D W Swinkels, H L M Lemmers, G M van der Vleuten, J de Graaf, A F H Stalenhoef.   

Abstract

BACKGROUND: Excess body iron is associated with increased cardiovascular disease risk, possibly via non-transferrin-bound iron (NTBI)-mediated enhancement of inflammation and oxidation of low-density lipoprotein (LDL).
METHODS: We assessed this proposed atherosclerotic mechanism of body iron by determining the relationship of levels of serum iron parameters, including NTBI, with plasma markers of inflammation and LDL oxidation in 232 subjects who visited the outpatient clinic for hemochromatosis family screening.
RESULTS: Plasma level of soluble intercellular adhesion molecule-1 (sICAM-1) was positively related to ferritin (standardized beta coefficient 0.16) and to NTBI (0.185) and negatively to total iron-binding capacity (TIBC, -0.166). Significant higher levels of sICAM-1 were found for subjects in the highest quartile of NTBI compared to the lowest quartile of NTBI (122 microg/L (107-141) and 106 microg/L (89-125), median (interquartile range), p<0.001). Odds ratio of subjects having sICAM-1 level above 134 microg/L (75th percentile) in the highest and lowest quartile of NTBI amounted 2.3. White blood cell count was positively related to ferritin (0.149). High-sensitivity C-reactive protein, interleukin-6, interleukin-8, oxidized LDL, oxidized LDL/apolipoprotein B and IgG and IgM antibodies to oxidized LDL were not related to any of the markers of iron status.
CONCLUSION: Excess body iron, reflected by elevated serum ferritin and NTBI and decreased TIBC, is associated with increased plasma level of sICAM-1 but not with markers of in vivo LDL oxidation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16963052     DOI: 10.1016/j.atherosclerosis.2006.08.012

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Vascular beneficial effects of polyphenol-rich olive oil and reduced body iron stores.

Authors:  Luca Mascitelli; Mark R Goldstein
Journal:  Eur J Nutr       Date:  2013-12       Impact factor: 5.614

Review 2.  Safety of iron fortification and supplementation in malaria-endemic areas.

Authors:  Gary M Brittenham
Journal:  Nestle Nutr Inst Workshop Ser       Date:  2012

3.  Circulating non-transferrin-bound iron after oral administration of supplemental and fortification doses of iron to healthy women: a randomized study.

Authors:  Gary M Brittenham; Maria Andersson; Ines Egli; Jasmin Tajeri Foman; Christophe Zeder; Mark E Westerman; Richard F Hurrell
Journal:  Am J Clin Nutr       Date:  2014-07-23       Impact factor: 7.045

Review 4.  Atherogenesis and iron: from epidemiology to cellular level.

Authors:  Francesca Vinchi; Martina U Muckenthaler; Milene C Da Silva; György Balla; József Balla; Viktória Jeney
Journal:  Front Pharmacol       Date:  2014-05-05       Impact factor: 5.810

5.  Effect of duration of packed red blood cell storage on morbidity and mortality in dogs after transfusion: 3,095 cases (2001-2010).

Authors:  L Hann; D C Brown; L G King; M B Callan
Journal:  J Vet Intern Med       Date:  2014-10-13       Impact factor: 3.333

6.  Analytical evaluation of serum non-transferrin-bound iron and its relationships with oxidative stress and cardiac load in the general population.

Authors:  Tomonori Sugiura; Yasuaki Dohi; Hiroyuki Takase; Satoshi Fujii; Yoshihiro Seo; Nobuyuki Ohte
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

7.  Nanoparticulate iron(III) oxo-hydroxide delivers safe iron that is well absorbed and utilised in humans.

Authors:  Dora I A Pereira; Sylvaine F A Bruggraber; Nuno Faria; Lynsey K Poots; Mani A Tagmount; Mohamad F Aslam; David M Frazer; Chris D Vulpe; Gregory J Anderson; Jonathan J Powell
Journal:  Nanomedicine       Date:  2014-06-28       Impact factor: 5.307

Review 8.  Signalling, Metabolic Pathways and Iron Homeostasis in Endothelial Cells in Health, Atherosclerosis and Alzheimer's Disease.

Authors:  Emy Bosseboeuf; Claudio Raimondi
Journal:  Cells       Date:  2020-09-08       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.